|
|
|
|
|
|
by yread
2656 days ago
|
|
|
Strange that the article doesn't mention Oncode institute [1], which has specific goals of repurposing generic and patent-expired drugs in combinations to lower costs and there were some discussions about making the drugs themselves [1]
https://www.oncode.nl/research/programs |
|
|